OM 85 to prevent lung infections in older nursing home residents
Part of Infections, Lungs & breathing clinical trials.
This study tests a medication called OM 85 that may help prevent respiratory infections (like pneumonia) in older adults living in nursing homes. If you are 75 or older and have had infections recently, this trial could be a way to stay healthier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 75 years old or older.
- You have had at least 2 respiratory infections (like pneumonia or bronchitis) in the past year.
- You live in a nursing home and have been there for at least 6 months, with plans to stay at least 6 more months.
- You are not expected to have a life-threatening illness (like cancer) that would shorten your life to less than a year.
- You are not allergic to any part of the study drug, have not had an organ transplant, and are not taking certain medications (like oral steroids).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a medicine called Ismigen can help children who get frequent respiratory infections (like colds, bronchitis, or throat infections) stay healthier. The medicine is made from bacterial components designed to strengthen the immune system.
This Phase 2 study tests a site-specific immune “booster” in people age 65 and older to help improve natural immunity and reduce respiratory (lung/airway) infections. You may be eligible if you can consent, are in an eligible living situation, and are not currently using certain immune-suppressing medicines.
This trial looks at antibiotic resistance by testing wastewater in nursing homes. It aims to understand how resistance spreads and how to better protect residents.
This study tests a pneumococcal vaccine designed for 20 types of bacteria in older adults who are hospitalized with suspected community-acquired pneumonia. It aims to see how the vaccine works in real-world care and whether it affects how pneumonia happens or progresses.
This study looks at how the immune system in the nose and throat reacts to Streptococcus pneumoniae bacteria and viruses in adults aged 60-85. It may help researchers find better ways to prevent or treat pneumonia.
This study tests new ways to diagnose pneumonia faster and more accurately in older adults who come to the emergency room with breathing problems. The goal is to see if these new tests work better than the current methods.
Hear when a new Respiratory Tract Infections (RTI) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.